Announcement on Obtaining Notice of Acceptance for Drug Clinical Trial Application of the Wholly-owned Subsidiary

About this update from Vcanbio Cell & Gene Engineering Corp., Ltd. Class A

Announcement on Obtaining Notice of Acceptance for Drug Clinical Trial Application of the Wholly-owned SubsidiaryThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Vcanbio Cell & Gene Engineering Corp., Ltd. Class A